Republic Healthcare Limited(HK:8357)
HK$0.140.00 (0.00%)
HK:8357
Republic Healthcare Limited financials statements
HK$0.14
At close:0.00 (0.00%)
Want to see HK:8357 full AI Analyst Report?
Republic Healthcare Limited (8357) Ratios
1 Followers
Republic Healthcare Limited Ratios
HK:8357's free cash flow for Q2 2026 was S$-305.64K. For the 2026 fiscal year, HK:8357's free cash flow was increased by S$0.00 and operating cash flow was S$-305.64K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.67 | 8.97 | 5.94 | 8.07 | 6.19 |
| Quick Ratio | 3.38 | 8.56 | 5.69 | 7.59 | 6.01 |
| Cash Ratio | 2.56 | 7.91 | 5.22 | 6.16 | 4.85 |
| Solvency Ratio | -0.31 | 0.01 | -0.02 | -0.21 | 0.24 |
| Operating Cash Flow Ratio | -0.76 | 0.09 | 0.39 | -0.42 | -0.19 |
| Short-Term Operating Cash Flow Coverage | -27.24 | 1.26 | 155.24 | 0.00 | -4.82 |
| Net Current Asset Value | S$ 2.59M | S$ 10.97M | S$ 10.67M | S$ 11.91M | S$ 13.11M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.06 | 0.06 | 0.05 | 0.08 |
| Debt-to-Equity Ratio | 0.53 | 0.07 | 0.08 | 0.06 | 0.10 |
| Debt-to-Capital Ratio | 0.35 | 0.06 | 0.07 | 0.05 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.69 | 1.15 | 1.23 | 1.16 | 1.24 |
| Debt Service Coverage Ratio | -5.26 | -1.25 | 0.04 | -7.29 | 4.40 |
| Interest Coverage Ratio | -10.30 | 36.19 | 34.85 | 22.13 | -11.63 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.78 | 55.67 | -374.06 | 25.84 | -12.04 |
| Profitability Margins | |||||
| Gross Profit Margin | -0.30% | 70.17% | 26.24% | 63.20% | 65.31% |
| EBIT Margin | -34.18% | -4.19% | -7.53% | -14.82% | -6.44% |
| EBITDA Margin | -22.45% | -2.05% | 0.29% | -4.11% | 6.89% |
| Operating Profit Margin | -34.18% | 18.42% | 18.27% | 13.39% | -9.79% |
| Pretax Profit Margin | -38.11% | -1.99% | -8.06% | -15.43% | -7.28% |
| Net Profit Margin | -37.79% | -1.93% | -8.32% | -15.73% | -7.14% |
| Continuous Operations Profit Margin | -37.79% | -1.93% | -8.32% | -15.73% | -7.14% |
| Net Income Per EBT | 99.15% | 97.06% | 103.25% | 101.96% | 98.03% |
| EBT Per EBIT | 111.49% | -10.80% | -44.10% | -115.19% | 74.42% |
| Return on Assets (ROA) | -18.37% | -1.23% | -5.47% | -9.04% | -5.18% |
| Return on Equity (ROE) | -31.04% | -1.42% | -6.71% | -10.52% | -6.40% |
| Return on Capital Employed (ROCE) | -19.66% | 13.03% | 14.06% | 8.63% | -8.26% |
| Return on Invested Capital (ROIC) | -17.98% | 12.22% | 13.56% | 8.43% | -7.68% |
| Return on Tangible Assets | -18.37% | -1.23% | -5.47% | -9.04% | -5.18% |
| Earnings Yield | -20.54% | -2.57% | -8.81% | -8.40% | -2.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.19 | 19.89 | 157.56 | 14.12 | 218.59 |
| Payables Turnover | 54.69 | 18.38 | 9.65 | 5.93 | 9.81 |
| Inventory Turnover | 10.78 | 4.68 | 5.70 | 3.58 | 8.97 |
| Fixed Asset Turnover | 1.27 | 10.20 | 7.74 | 7.05 | 5.75 |
| Asset Turnover | 0.49 | 0.64 | 0.66 | 0.58 | 0.73 |
| Working Capital Turnover Ratio | 0.87 | 0.81 | 0.87 | 0.71 | 1.11 |
| Cash Conversion Cycle | 71.74 | 76.40 | 28.54 | 66.13 | 5.14 |
| Days of Sales Outstanding | 44.55 | 18.35 | 2.32 | 25.85 | 1.67 |
| Days of Inventory Outstanding | 33.86 | 77.91 | 64.05 | 101.85 | 40.68 |
| Days of Payables Outstanding | 6.67 | 19.86 | 37.82 | 61.57 | 37.21 |
| Operating Cycle | 78.41 | 96.26 | 66.36 | 127.70 | 42.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -1.55 | 1.69 | 9.61 | -1.73 | -0.82 |
| Capital Expenditure Coverage Ratio | -1.55 | 1.69 | 9.61 | -1.73 | -0.82 |
| Operating Cash Flow Coverage Ratio | -0.38 | 0.15 | 0.94 | -0.91 | -0.33 |
| Operating Cash Flow to Sales Ratio | -0.24 | 0.01 | 0.09 | -0.08 | -0.04 |
| Free Cash Flow Yield | -21.58% | 0.74% | 8.31% | -6.55% | -3.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.82 | -38.84 | -11.35 | -11.90 | -34.84 |
| Price-to-Sales (P/S) Ratio | 1.84 | 0.75 | 0.94 | 1.87 | 2.49 |
| Price-to-Book (P/B) Ratio | 1.51 | 0.55 | 0.76 | 1.25 | 2.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.63 | 134.99 | 12.04 | -15.26 | -30.77 |
| Price-to-Operating Cash Flow Ratio | -7.62 | 55.33 | 10.78 | -24.06 | -68.16 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.49 | 0.27 | -0.36 | -0.07 |
| Enterprise Value Multiple | -7.41 | 19.01 | -43.23 | -19.71 | 24.06 |
| Enterprise Value | 13.05M | -3.59M | -1.27M | 7.64M | 23.17M |
| EV to EBITDA | -7.41 | 19.01 | -43.23 | -19.71 | 24.06 |
| EV to Sales | 1.66 | -0.39 | -0.12 | 0.81 | 1.66 |
| EV to Free Cash Flow | -4.19 | -70.01 | -1.57 | -6.60 | -20.51 |
| EV to Operating Cash Flow | -6.89 | -28.70 | -1.41 | -10.41 | -45.43 |
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Shareholders’ Equity Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.03 | -0.03 | -0.02 | 0.02 |
| Revenue Per Share | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 0.99 | 0.97 | 1.03 | 1.02 | 0.98 |
| Interest Burden | 1.11 | 0.48 | 1.07 | 1.04 | 1.13 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.34 | 0.06 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.64 | -0.68 | -1.09 | 0.51 | 0.50 |
Currency in SGD

